High Prevalence of Hypothyroidism and Approval and Launch of New Products to Augment Growth of Liothyronine Market
Liothyronine is used to treat an underactive thyroid (hypothyroidism) and myxedema coma. It is a manufactured form of the thyroid hormone triiodothyronine. Market Dynamics High prevalence of hypothyroidism is expected to propel growth of the global liothyronine market . For instance, the study ‘Prevalence of hypothyroidism in patients with type 2 diabetes mellitus and hypertension in India: a cross-sectional observational study’, reported that the prevalence of hypothyroidism in patients with type 2 diabetes mellitus, hypertension, and type 2 diabetes mellitus + hypertension was 24.8%, 33.5%, and 28.9%, respectively. High prevalence of diabetes is also expected to aid in growth of the global liothyronine market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research an...